首页 | 本学科首页   官方微博 | 高级检索  
检索        

血清肿瘤标志物预测乳腺癌骨转移的价值
引用本文:何小江,俞浩,吴华,黄劲雄,俞丹,苏新辉.血清肿瘤标志物预测乳腺癌骨转移的价值[J].肿瘤防治研究,2006,33(8):583-584.
作者姓名:何小江  俞浩  吴华  黄劲雄  俞丹  苏新辉
作者单位:福建医科大学附属厦门市第一医院核医学科;
摘    要:目的探讨血清肿瘤标志物预测乳腺癌骨转移的临床价值。方法应用化学发光免疫检测技术检测174例乳腺癌患者血清CA153、CA125、CEA、FER等四种肿瘤标志物,同时应用SPECT对所有患者行全身骨扫描检查,以明确有无骨转移。结果174例患者中55例临床诊断为乳腺癌骨转移。CA153、CA125、CEA、FER对诊断骨转移的阳性预测价值分别为68.0%(34/50),70.0%(14/20),88.9%(8/9),53.8%(14/26),阴性预测价值分别为86.2%(106/123),89.0%(130/146),73.2%(115/157),75.9%(85/112)。一种以上标志物同时阳性或阴性者,其阳性或阴性预测价值增加。结论CA153、CA125、CEA、FER具有预测乳腺癌骨转移的临床价值,联合检测CA153、CA125、CEA、FER能提高其预测乳腺癌骨转移的准确性。

关 键 词:血清肿瘤标志物  全身骨扫描  乳腺癌  骨转移  预测价值  
文章编号:1000-8578(2006)08-0583-02
收稿时间:2005-09-07
修稿时间:2005-09-072005-11-25

Value of Serum Tumor Markers in Predicting Bone Metastases of Breast Cancer
HE Xiao-jiang,YU Hao,WU Hua,HUANG Jin-xiong,YU Dan,SU Xin-hui.Value of Serum Tumor Markers in Predicting Bone Metastases of Breast Cancer[J].Cancer Research on Prevention and Treatment,2006,33(8):583-584.
Authors:HE Xiao-jiang  YU Hao  WU Hua  HUANG Jin-xiong  YU Dan  SU Xin-hui
Institution:The First Hospital of Xiamen; Fujian Medical Universty; Xiamen 361003; China;
Abstract:Objective To explore the value of serum tumor markers in predicting bone metastases of breast cancer.Methods Serum tumor markers (CA153、CA125、CEA、FER ) were assayed with CLIA and whole body bone scan were investigated with SPECT on 174 breast cancer patients.Results Of 174 patients,55 were diagnosed as bone metastases with whole body bone scan.The positive predicting values of CA153、CA125、CEA、FER were 68.0%(34/50),70.0%(14/20),88.9%(8/9),53.8%(14/26),and the negative predicting values of CA153、CA125、CEA、FER...
Keywords:Serum tumor marker  Whole body bone scan  Breast cancer  Bone metastases  Predicting value
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号